Plain-English translation of NCT07198581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether an AI-powered system can help doctors better manage the side effects of chemotherapy. The system analyzes your symptoms during regular clinic visits and suggests management strategies to your doctor, who then decides whether to use those suggestions. The goal is to help you feel better during cancer treatment and maintain your quality of life.
Most patients receiving chemotherapy experience side effects like nausea, fatigue, pain, and digestive problems that can affect their quality of life and sometimes lead to treatment delays or dose reductions. Doctors often have limited time to address every side effect, so this new treatment is designed to help catch and manage these problems more consistently.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive standard chemotherapy and be randomly assigned to either the standard care group or the AI-assisted group. If you are in the AI group, your doctor will share your symptom information (without your name) with an AI system during your regular clinic visits, and the AI will suggest ways to manage your side effects for your doctor to review. You will attend your normal chemotherapy appointments and report how you are feeling, and researchers will track your side effects and quality of life throughout your treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
South Korea